Quick Answer
Silo Pharma, Inc. reported Total Revenue of $72.1 thousand for fiscal year 2025.
Silo Pharma, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $72.1K | +0.0% |
| 2024 | $72.1K | +0.0% |
| 2023 | $72.1K | +0.0% |
| 2022 | $72.1K | +76.2% |
| 2020 | $40.9K | +0.9% |
| 2019 | $40.6K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.0K | +0.0% | +0.0% |
| June 30, 2025 | $18.0K | +0.0% | -0.0% |
| March 31, 2025 | $18.0K | +0.0% | +0.0% |
| September 30, 2024 | $18.0K | +0.0% | +0.0% |
| June 30, 2024 | $18.0K | +0.0% | -0.0% |
| March 31, 2024 | $18.0K | +0.0% | +0.0% |
| September 30, 2023 | $18.0K | +0.0% | +0.0% |
| June 30, 2023 | $18.0K | +0.0% | -0.0% |
- Silo Pharma, Inc. showed an increase of +0.0% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Silo Pharma, Inc.’s total revenue has grown by 77.7% (from $40.6 thousand to $72.1 thousand).
- The most recent figure is from Silo Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: